ArticleBioengineering (Basel, Switzerland)2026
Benign Share Benefit to Malignant: Balanced Mixing on Feature Space for Imbalanced Breast Cancer Classification.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A deep learning model with an imbalanced mammography dataset can bias models toward common benign BI-RADS categories and reduce recognition of less frequent malignant or high-risk categories. To address this issue, we propose B2M (Benign Share Benefit to Malignant), a model-agnostic framework for imbalance-aware multi-class BI-RADS classification in C-View mammography. B2M uses a two-phase training strategy that combines dual sampling with feature-space mixing. In Phase I, the model is trained with dual sampling, integrating instance-based and class-balanced sampling to increase minority-class representation while preserving majority-class diversity. In Phase II, the model is fine-tuned with feature-space mixing using samples from the two sampling streams. A soft-target regularization objective supervises the mixed features using labels from both streams, encouraging smoother decision boundaries across BI-RADS categories. We evaluated B2M on an imbalanced mammography cohort from the C-View EMBED dataset using stratified 5-fold cross-validation across multiple CNN backbones. C-View is a synthesized 2D mammographic image generated from 3D digital breast tomosynthesis data, capturing DBT-derived structural information while requiring less memory and computation than processing the full 3D image volume. Among these experiments, ResNeXt-50 with B2M achieved the highest balanced accuracy and Macro-F1 scores compared with the evaluated oversampling and mixing-based methods. This improvement requires an offline training-time overhead of approximately 2.81×, but it does not increase inference cost. Overall, the results suggest that B2M may be useful for imbalanced multi-class BI-RADS classification in C-View mammography. However, the findings are based on the EMBED cohort, and further validation, including external and prospective evaluation, is needed before clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.